Edition:
India

Kaken Pharmaceutical Co Ltd (4521.T)

4521.T on Tokyo Stock Exchange

5,430JPY
23 Jul 2019
Change (% chg)

-- (--)
Prev Close
¥5,430
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
109,147
52-wk High
¥6,120
52-wk Low
¥4,535

Latest Key Developments (Source: Significant Developments)

Kaken Pharmaceutical signs exclusive distribution agreement for Clenafin/Jublia in Taiwan
Wednesday, 8 Nov 2017 

Nov 8 (Reuters) - Kaken Pharmaceutical Co Ltd <4521.T>:Says co signed an exclusive distribution agreement with Tai Tien Pharmaceuticals Co Ltd (Tai Tien), which is a subsidiary of Mitsubishi Tanabe Pharma Corporation <<<4508.T>>>, for the topical formulation for Onychomycosis "Clenafin/Jublia" (product) in Taiwan.According to the agreement, co grants to Tai Tien the exclusive right for sales of the product in Taiwan and Tai Tien expects to launch the product in 2018.  Full Article